Developing a Regulatory Strategy
What is a regulatory strategy? And for that matter, what do people sometimes think is a regulatory strategy but isn’t? Those are the questions that today’s guest, Mike Drues, discusses as he begins his conversation with host John Speer, founder of Greenlight Guru. Mike is President of Vascular Sciences, an education, training, and consulting company that offers many services to medical device, pharmaceutical, and biotechnology companies. Listen to the episode to learn how Mike thinks about competitive regulatory strategy, delays in complying with regulation, and reimbursement and regulatory strategy.

▶︎
QSR to QMSR: The Rewrite of 21 CFR Part 820 & Key Considerations for FDA Compliance

▶︎
Implementing an eQMS: The Ultimate Move-In Guide for MedTech Leaders

▶︎
Injecting Compliance into Code: Automating Compliance with AI in the MedTech SDLC

▶︎
Forming Up A Regulatory Strategy: When And How To Start

▶︎
Developing your regulatory strategies across pharma development and approval: UK, Euro and US models

▶︎
FDA aligns QMSR with ISO 13485?

▶︎
The non-BS QMS for software enabled medical devices

▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

▶︎
Advancing Transparency and Regulatory Science Activities on Risk Evaluation and Mitigation Strategy

▶︎
How to work with a medtech CRO and stay in control

▶︎
GLP-1 Ripple Effect: Reshaping Injectable Drug Delivery

▶︎
Move Fast and Stay Compliant: Rethinking Change Control for Software Medical Devices in Europe

▶︎
Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!

▶︎
FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Devices Day 1

▶︎
Mass-Manufacturing a 5-in-1 Ventilator System for COVID-19 Relief

▶︎
What does a strategy for regulatory compliance looks like?

▶︎
Dave Ricks, CEO of Eli Lilly: How a 150 Year Old Company Keeps Winning

▶︎
How to Focus to Change Your Brain | Huberman Lab Essentials

▶︎
What's The Function: Regulatory Strategy

▶︎
